Clinical Trial

A Study on Immunotherapy Combined With Radiotherapy for Esophagogastric Junction/Gastric Adenocarcinoma

Name: A Study on Immunotherapy Combined With Radiotherapy for Esophagogastric Junction/Gastric Adenocarcinoma — clinical trial record (NCT07053332)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A single-arm, prospective phase II clinical study of neoadjuvant PD-1/CTLA-4 combination antibody with low-dose radiotherapy in resectable dMMR/MSI-H esophagogastric junction/gastric adenocarcinoma.

Trial Details

NCT Number	NCT07053332
Lead Sponsor	Jiangsu Cancer Institute & Hospital
Conditions	Esophagogastric Junction/Gastric Adenocarcinoma
Enrollment	20 participants
Start Date	2025-07
Primary Completion	2027-12 (estimated)
Study Completion	2029-08-12 (estimated)
Updated on ClinicalTrials.gov	2025-07-08